drugset / Trial / NCT07240454
Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma
Recruiting
143 enrolled
Tao Liu
Tianjin Medical University General Hospital · collabXuanwu Hospital, Beijing · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration. By participating in this study, participants can receive additional scientific guidance on aspirin medication management beyond routine conservative treatment, thereby optimizing individualized therapy.
Timeline
- Start
- 2025-10-15
- Primary completion
- 2027-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 100 mg | Oral |
Indications
No indication recorded.